Genoray Co. Ltd (122310) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.057x

Based on the latest financial reports, Genoray Co. Ltd (122310) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.78 Billion ≈ $3.24 Million USD) by net assets (₩83.75 Billion ≈ $56.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Genoray Co. Ltd (122310) net asset quality to measure how much of total assets are equity-financed.

Genoray Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Genoray Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 122310 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Genoray Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genoray Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Implanet SA PA:ALIMP	-0.700x
Aquaron Acquisition Corp. Common Stock NASDAQ:AQU	-0.032x
Hill & Smith Holdings PLC LSE:HILS	0.131x
Pergamon Status Dis Ticaret AS IS:PSDTC	-0.002x
Cantex Mine Development Corp V:CD	-1.416x
Hyungkuk F&B Co Ltd KQ:189980	0.069x
North Energy ASA OL:NORTH	-0.013x
Sunson Textile Manufacturer JK:SSTM	0.006x

Annual Cash Flow Conversion Efficiency for Genoray Co. Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Genoray Co. Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Genoray Co. Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩83.75 Billion ≈ $56.76 Million	₩5.26 Billion ≈ $3.56 Million	0.063x	-59.38%
2024-12-31	₩85.89 Billion ≈ $58.21 Million	₩13.27 Billion ≈ $9.00 Million	0.155x	+315.37%
2023-12-31	₩95.53 Billion ≈ $64.74 Million	₩3.55 Billion ≈ $2.41 Million	0.037x	-77.94%
2022-12-31	₩87.96 Billion ≈ $59.61 Million	₩14.84 Billion ≈ $10.05 Million	0.169x	-13.58%
2021-12-31	₩78.82 Billion ≈ $53.41 Million	₩15.38 Billion ≈ $10.43 Million	0.195x	+52.63%
2020-12-31	₩66.53 Billion ≈ $45.08 Million	₩8.51 Billion ≈ $5.77 Million	0.128x	-28.49%
2019-12-31	₩59.59 Billion ≈ $40.38 Million	₩10.65 Billion ≈ $7.22 Million	0.179x	+16.67%
2018-12-31	₩44.97 Billion ≈ $30.48 Million	₩6.89 Billion ≈ $4.67 Million	0.153x	-16.72%
2017-12-31	₩24.30 Billion ≈ $16.47 Million	₩4.47 Billion ≈ $3.03 Million	0.184x	-21.57%
2016-12-31	₩14.80 Billion ≈ $10.03 Million	₩3.47 Billion ≈ $2.35 Million	0.235x	+26.88%
2015-12-31	₩11.35 Billion ≈ $7.69 Million	₩2.10 Billion ≈ $1.42 Million	0.185x	--

About Genoray Co. Ltd

KQ:122310 Korea Diagnostics & Research

Market Cap

$28.15 Million

₩41.54 Billion KRW

Market Cap Rank

#23924 Global

#1636 in Korea

Share Price

₩3420.00

Change (1 day)

-1.16%

52-Week Range

₩3200.00 - ₩5620.00

All Time High

₩11740.92